Skip to main content

Month: December 2020

Oil-Dri Announces Strong First Quarter of Fiscal 2021 and Record First Quarter Net Sales

CHICAGO, Dec. 07, 2020 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year 2021.Daniel S. Jaffee, President and Chief Executive Officer, stated, “Coming off of a year with record sales and net income, I am extremely pleased that our momentum has continued into the first quarter of fiscal 2021. These solid results demonstrate how we are succeeding in our mission to Create Value from Sorbent Minerals as we align with a diversified customer base spanning many different industries and countries. Revenues from cat litter remain strong both domestically and internationally, as more consumers embrace the value of our lightweight litter. We achieved sales gains within our Business to Business (“B2B”) Products Group...

Continue reading

New York Mortgage Trust Declares Fourth Quarter 2020 Common Stock Dividend of $0.10 Per Share, and Preferred Stock Dividends

NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.10 per share on shares of its common stock for the quarter ending December 31, 2020. The dividend will be payable on January 25, 2021 to common stockholders of record as of the close of business on December 17, 2020.In addition, the Board declared cash dividends for the quarterly period that began on October 15, 2020 and ends on January 14, 2021 on the Company’s 7.75% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”), 7.875% Series C Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”), 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series D Preferred...

Continue reading

Harpoon Therapeutics to Host Clinical Pipeline Programs Update Call and Webcast on December 8, 2020

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that it will host a conference call and webcast to review the status and provide a clinical update for its three most advanced TriTAC® programs. The discussion will be focused on HPN424 for the treatment of metastatic castration resistant prostate cancer, HPN536 initially in development for ovarian and pancreatic cancer and mesothelioma, and HPN217 for relapsed/refractory multiple myeloma.The live call/webcast will take place at 8 a.m. ET / 5 a.m. PT on December 8, 2020 and can be accessed by dialing (866) 951-6894 for domestic callers and (409) 216-0624 for international callers with conference ID code number 1388395. A webcast...

Continue reading

Tricida to Provide an End-of-Year Business Update

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that it will provide an end-of-year business update on veverimer’s development program, regulatory status and patent protection.Tricida will host a conference call and webcast at 4:30 pm Eastern Time on December 8, 2020. The webcast, including slides, or conference call may be accessed as follows:A replay of the webcast will be available on Tricida’s website approximately two hours following the completion of the call and will be available for up to 90 days following the...

Continue reading

Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors

TUSTIN, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of Jeanne Thoma as an independent member of the company’s board of directors. Ms. Thoma is a seasoned pharmaceutical industry executive with more than 30 years of experience spanning product development and commercialization, as well as operations and supply chain management.“On behalf of the entire board, I am delighted to welcome Ms. Thoma with her extensive pharmaceutical industry expertise to the Avid board of directors,” said Joseph Carleone, Ph.D., Avid’s chairman of the...

Continue reading

Financial Institutions, Inc. Announces Agreement to Acquire Landmark Group

 –  Rochester, New York Insurance brokerage firm will be acquired by SDN Insurance Agency, Financial Institutions’ insurance subsidiary–  Landmark principals Kelly M. Shea and Christopher K. Shea will remain with SDN Insurance to lead Rochester operations and manage Landmark accountsWARSAW, N.Y., Dec. 07, 2020 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), parent company of Five Star Bank (the “Bank”), SDN Insurance Agency, LLC (“SDN”), Courier Capital, LLC (“Courier Capital”) and HNP Capital, LLC (“HNP Capital”), today announced a definitive agreement for the acquisition of the assets of Landmark Group (“Landmark”) by the Company’s insurance subsidiary SDN.A staple of the Rochester community since 1984, Landmark is an independent insurance brokerage firm delivering insurance, surety and...

Continue reading

Stitch Fix Announces Dan Jedda As New CFO, Joining the Company From Amazon

SAN FRANCISCO, Dec. 07, 2020 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, announced that Dan Jedda has joined the company, reporting to Katrina Lake. Jedda will be appointed CFO effective December 9, 2020. Dan Jedda joins the company from Amazon where he was Vice President and CFO for Digital Video (including Amazon Studios), Digital Music, and the Advertising and Corporate Development organizations. During his 15-year career at Amazon, Jedda enabled explosive growth in these businesses and was with many of them since their inception. He has deep experience identifying and investing in market-defining consumer experiences.“I’m excited to welcome Dan Jedda to our team,” said Stitch Fix founder and CEO Katrina Lake. “Dan brings extensive experience funding and scaling some of the...

Continue reading

HealthEquity Reports Third Quarter Ended October 31, 2020 Financial Results

Highlights of the third quarter include:Revenue of $179.4 million, an increase of 14% compared to $157.1 million in Q3 FY20.Net income of $1.8 million, with non-GAAP net income of $32.2 million, compared to net loss of $21.3 million and non-GAAP net income of $30.3 million in Q3 FY20.Net income per diluted share of $0.02, with non-GAAP net income per diluted share of $0.41, compared to net loss per diluted share of $0.30 and non-GAAP net income per diluted share of $0.43 in Q3 FY20.Adjusted EBITDA of $61.1 million, an increase of 10% compared to $55.5 million in Q3 FY20.5.5 million HSAs, an increase of 9% compared to Q3 FY20.$12.4 billion Total HSA Assets, an increase of 19% compared to Q3 FY20.12.5 million Total Accounts, including both HSAs and complementary CDB accounts, the same as in Q3 FY20.DRAPER, Utah, Dec. 07, 2020 (GLOBE NEWSWIRE)...

Continue reading

Maple Gold Announces $10 Million Bought Deal Financing

Not for distribution to U.S. news wire services or dissemination in the United States.MONTREAL, Dec. 07, 2020 (GLOBE NEWSWIRE) — Maple Gold Mines Ltd. (TSX-V: MGM) (OTCQB: MGMLF) (FSE: M3G) (“Maple Gold” or the “Company”) has announced today that it has entered into an agreement with BMO Capital Markets (“BMO” or the “Underwriter”), under which the Underwriter has agreed to buy on bought deal basis 27,800,000 common shares of the Company (the “Common Shares”), at a price of C$0.36 per Common Share for gross proceeds of approximately C$10 million (the “Offering”). The Company has also granted the Underwriter an option, exercisable in whole or in part at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any. The Offering...

Continue reading

Klövern announces the final outcome of preferential rights issue

THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER COUNTRY WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES. ADDITIONAL TERMS AND CONDITIONS APPLY. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THIS PRESS RELEASE. The final outcome of the preferential rights issue in Klövern AB (publ) (“Klövern” or the “Company”) shows that 17,104,484 ordinary shares of series A and 186,451,359 ordinary shares of series B, corresponding to 98.6 per cent of the offered ordinary shares of series A and 98.7 per cent of offered ordinary shares of series B, have been subscribed for by exercising subscription rights. The remaining...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.